Andere Sprachen ALX Oncology Holdings Inc.

Aktien

A2P79Z

US00166B1052

ALXO

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 25.04.2024			% 5 Tage	% 1. Jan.
16,87 ^USD	+4,01 %		+7,18 %	+13,30 %

18.04.	Alx Oncology Holdings Insider verkaufte Aktien im Wert von $710.195, laut einer aktuellen SEC Einreichung	MT
10.04.	ALX Oncology meldet positive Daten aus laufender Phase 1/2-Studie mit Evorpacept	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting	24.04.
Alx Oncology Holdings Insider Sold Shares Worth $710,195, According to a Recent SEC Filing	18.04.
ALX Oncology Reports Positive Data From Ongoing Phase 1/2 Trial of Evorpacept	10.04.
ALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in an Ongoing Phase 1/2 Clinical Trial in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (“R/R B-NHL”)	09.04.
ALX Oncology Holdings Inc. Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in an Ongoing Phase 1/2 Clinical Trial in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (?R/R B-NHL?)	09.04.
ALX Oncology : Corporate Presentation	11.03.
North American Morning Briefing : Stock Futures -2-	11.03.
ALX Oncology Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07.03.
ALX Oncology Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	07.03.
ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	07.03.
ALX Oncology Announces Two Evorpacept Clinical Abstracts Accepted for Presentation at the AACR Annual Meeting	05.03.
ALX Oncology Announces Two Evorpacept Clinical Abstracts Accepted for Presentation at the AACR Annual Meeting	05.03.
ALX Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03.01.
ALX Oncology Holdings Inc. and ALX Oncology Inc. Enter into the Third Amendment to Loan and Security Agreement	26.12.
North American Morning Briefing : Investors Await -2-	11.12.
Top Midday Gainers	08.12.
Sector Update: Health Care Stocks Advance Premarket Tuesday	14.11.
ALX Oncology Reports Q3 Results With 'Sufficient' Funds to Finance Operations Into Early 2026	13.11.
ALX Oncology Q3 Net Loss Widens; Shares Ease After Hours	13.11.
ALX Oncology Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen ALX Oncology Holdings Inc.

Aktien

A2P79Z

US00166B1052

ALXO

Andere Sprachen

Filter